Promentis Pharmaceuticals Company Culture
Promentis Pharmaceuticals Culture
This score is derived from employee ratings & reviewsTop Rated Culture Dimensions
Share Your Opinion
Anonymously Rate Your Experience & Make Work BetterPromentis Pharmaceuticals Company Information
Promentis Pharmaceuticals Company Overview
Promentis Pharmaceuticals focuses on developing antipsychotic drugs to treat schizophrenia.
| Headquarter | 826 N. PLANKINTON AVE., STE. 400 Milwaukee, WI United States of America |
|---|---|
| Website | www.promentispharma.com |
| Founding Date | 2006 |
| Tel | (414)238-2992 |
| Company Status | Private |
Promentis Pharmaceuticals Competitors
Promentis Pharmaceuticals competitors include Biogen, MyoKardia, and Alexza Pharmaceuticals. See below how Promentis Pharmaceuticals compares to its competitors with CEO Rankings, Product & Services, NPS, Pricing, Customer Services, Overall Culture Score, eNPS, Gender and Diversity Scores.
Promentis Pharmaceuticals CEO & Leadership
Promentis Pharmaceuticals CEO - Klaus Veitinger
Promentis Pharmaceuticals Leadership
Klaus Veitinger CEO / President
Klaus Veitinger serves as the CEO / President of Promentis Pharmaceuticals.
Chad Beyer SVP of R&D
Chad Beyer serves as the SVP of R&D of Promentis Pharmaceuticals.
Promentis Pharmaceuticals Careers
Promentis Pharmaceuticals Jobs
No Recent Jobs found for Promentis Pharmaceuticals on Comparably
Mark that you are interested and we will alert you when there are new positions available listed on Comparably
Let Promentis Pharmaceuticals Know You Want To Work There
Overview of Candidates Interested in Promentis Pharmaceuticals on Comparably
Candidates By Department
Customer Support | 100% |
|---|
Candidates By Location
Milwaukee | 100% |
|---|
Frequently Asked Questions regarding Promentis Pharmaceuticals
What is Promentis Pharmaceuticals address?
Promentis Pharmaceuticals location is at 826 N. PLANKINTON AVE., STE. 400
Who are Promentis Pharmaceuticals competitors?
Promentis Pharmaceuticals main competitors are Biogen, MyoKardia, Alexza Pharmaceuticals
Who is Promentis Pharmaceuticals leadership?
Chad Beyer are part of Promentis Pharmaceuticals leadership, Klaus Veitinger is the CEO
×